Clinical Trial Update: Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant hepatic arterial infusion chemotherapy with GEMOX plus adebrelimab and lenvatinib for resectable intrahepatic cholangiocarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING